MyState Limited
MyState Limited (MYS.AX) Financial Performance & Income Statement Overview
Review MyState Limited (MYS.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
MyState Limited (MYS.AX) Income Statement & Financial Overview
View the income breakdown for MyState Limited MYS.AX across both annual and quarterly reports.
Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
---|---|---|---|---|
Revenue | $77.76M | $76.35M | $247.38M | $214.32M |
Cost of Revenue | $0.00 | -$183.09M | $0.00 | $0.00 |
Gross Profit | $77.76M | $259.44M | $247.38M | $214.32M |
Gross Profit Ratio | $1.00 | $3.40 | $1.00 | $1.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $51.32M | $50.56M | $48.14M | $49.12M |
Operating Expenses | $51.32M | $25.28M | $25.40M | $27.28M |
Total Costs & Expenses | $51.32M | $234.28M | $222.34M | $187.88M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $64.62M | $54.58M | $4.55M |
Depreciation & Amortization | $0.00 | $3.47M | $3.82M | $3.58M |
EBITDA | $25.02M | $28.63M | $0.00 | $0.00 |
EBITDA Ratio | $0.32 | $0.37 | $0.00 | $0.02 |
Operating Income | $26.43M | $25.16M | $25.05M | $26.44M |
Operating Income Ratio | $0.34 | $0.33 | $0.10 | $0.12 |
Other Income/Expenses (Net) | -$2.98M | $0.00 | $0.00 | $0.00 |
Income Before Tax | $23.45M | $25.16M | $25.05M | $26.44M |
Income Before Tax Ratio | $0.30 | $0.33 | $0.10 | $0.12 |
Income Tax Expense | $7.54M | $7.34M | $7.57M | $7.99M |
Net Income | $15.92M | $17.82M | $17.47M | $18.45M |
Net Income Ratio | $0.20 | $0.23 | $0.07 | $0.09 |
EPS | $0.13 | $0.18 | $0.16 | $0.17 |
Diluted EPS | $0.11 | $0.14 | $0.14 | $0.15 |
Weighted Avg Shares Outstanding | $122.31M | $110.45M | $109.99M | $109.42M |
Weighted Avg Shares Outstanding (Diluted) | $140.77M | $140.24M | $139.78M | $139.26M |
Over the last four quarters, MyState Limited achieved steady financial progress, growing revenue from $214.32M in Q4 2023 to $77.76M in Q2 2025. Gross profit stayed firm with margins at 100% in Q2 2025 versus 100% in Q4 2023. Operating income totaled $26.43M in Q2 2025, maintaining a 34% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $25.02M. Net income dropped to $15.92M, with EPS at $0.13. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan